(Q43039435)

English

Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience

scientific article published on 20 July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

Ajit Sood

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Vandana Midha

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Syed Hissar

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Manoj Kumar

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Pothakamuri V Suneetha

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Manu Bansal

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Nina Sood

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Puja Sakhuja

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shiv K Sarin

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

20 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

203-207

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Diagnosis of hepatitis C virus-associated chronic liver disease in India: comparison of HCV antibody assay with a polymerase chain reaction for the 5' noncoding region

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05057.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05057.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05057.X

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05057.X

21 January 2018

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05057.X

21 January 2018

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05057.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2007.05057.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039435&oldid=1978308099"